Community Hospital East to offer new melanoma treatment

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

[FILE] A dcotor with a stethoscope stands in a doorway at Emory Hospital in Atlanta, Georgia.

INDIANAPOLIS (April 24, 2016) — An Indianapolis hospital will begin treating melanoma patients with a new drug that uses a modified virus to infiltrate and destroy deadly skin cancer tumors.

Community Hospital East says it will soon start treating patients with the injectable drug from Amgen Inc. for patients with hard-to-treat melanoma.

The drug, Imlygic, is injected directly into tumor tissue, where it uses the herpes virus as a Trojan horse to slip past and rupture cancer cells. It also creates an anti-tumor response in patient’s immune system.

The virus is modified so that it only replicates within cancer cells, while leaving healthy cells alone.

This immunotherapy drug was approved late last year by the Food and Drug Administration.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.